Evaluation of the Mirasol platelet reduction technology system against Babesia microti in apheresis platelets and plasma

Transfusion

Volumn 50, Issue 5, 2010, Pages 1019-1027

  Tonnetti, Laura ^a,b   Proctor, Melanie C ^a,b   Reddy, Heather L ^a,b   Goodrich, Raymond P ^a,b   Leiby, David A ^a,b  

^a HOLLAND LABORATORY   (United States)

^b CaridianBCT Biotechnologies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RIBOFLAVIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APHERESIS; ARTICLE; BABESIA MICROTI; BLOOD SMEAR; BLOODSTREAM INFECTION; CONTROLLED STUDY; HAMSTER; INOCULATION; MICROSCOPY; NONHUMAN; PATHOGENESIS; PLASMA; REAL TIME POLYMERASE CHAIN REACTION; REDUCTION; RISK REDUCTION; THROMBOCYTE; ULTRAVIOLET RADIATION;

ANIMALS; BABESIA MICROTI; BABESIOSIS; BLOOD PLATELETS; CRICETINAE; HUMANS; PLASMAPHERESIS; PLATELETPHERESIS; POLYMERASE CHAIN REACTION; RIBOFLAVIN; ULTRAVIOLET RAYS;

EID: 77951678635     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2009.02538.x     Document Type: Article

References (26)

1. Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 2004 44 : 877 85. (Pubitemid 38738418)
2. Fast LD, Dileone G, Li J, Goodrich R. Functional inactivation of white blood cells by Mirasol treatment. Transfusion 2006 46 : 642 8.
3. Fast LD, DiLeone G, Cardarelli G, Li J, Goodrich R. Mirasol PRT treatment of donor white blood cells prevents the development of xenogeneic graft-versus-host disease in Rag2-/-gamma c-/- double knockout mice. Transfusion 2006 46 : 1553 60. (Pubitemid 44326331)
4. Asano H, Lee CY, Fox-Talbot K, Koh CM, Erdinc MM, Marschner S, Keil S, Goodrich RP, Baldwin WM 3rd. Treatment with riboflavin and ultraviolet light prevents alloimmunization to platelet transfusions and cardiac transplants. Transplantation 2007 84 : 1174 82. (Pubitemid 350125361)
5. Reddy HL, Dayan AD, Cavagnaro J, Gad S, Li J, Goodrich RP. Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation. Transfus Med Rev 2008 22 : 133 53. (Pubitemid 351384824)
6. Cardo LJ, Rentas FJ, Ketchum L, Salata J, Harman R, Melvin W, Weina PJ, Mendez J, Reddy H, Goodrich R. Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light. Vox Sang 2006 90 : 85 91. (Pubitemid 43381495)
7. Cardo LJ, Salata J, Mendez J, Reddi H, Goodrich R. Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light. Transfus Apher Sci 2007 37 : 131 7. (Pubitemid 350181574)
8. Rentas F, Harman R, Gomez C, Salata J, Childs J, Silva T, Lippert L, Montgomery J, Richards A, Chan C, Jiang J, Reddy H, Li J, Goodrich R. Inactivation of Orientia tsutsugamushi in red blood cells, plasma and platelets with riboflavin and light, as demonstrated in an animal model. Transfusion 2007 47 : 240 7. (Pubitemid 46146557)
9. Leiby DA. Babesiosis and blood transfusion: flying under the radar. Vox Sang 2006 90 : 157 65.
10. Meldrum SC, Birkhead GS, White DJ, Benach JL, Morse DL. Human babesiosis in New York State: an epidemiological description of 136 cases. Clin Infect Dis 1992 15 : 1019 23.
11. Eberhard ML, Walker EM, Steurer FJ. Survival and infectivity of Babesia in blood maintained at 25°C and 2-4°C. J Parasitol 1995 81 : 790 2.
12. Mintz ED, Anderson JF, Cable RG, Hadler JL. Transfusion-transmitted babesiosis: a case report from a new endemic area. Transfusion 1991 31 : 365 8.
13. Gubernot DM, Lucey CT, Lee KC, Conley GB, Holness LG, Wise RP. Babesia infection through blood transfusions: reports received by the US Food and Drug Administration, 1997-2007. CID 2009 48 : 25 30.
14. Tonnetti L, Eder AF, Dy B, Kennedy J, Pisciotto P, Benjamin RJ, Leiby DA. Transfusion-transmitted Babesia microti identified through hemovigilance. Transfusion. In press 2009.
15. Pantanowitz L, Telford SR III., Cannon ME. The impact of babesiosis on transfusion medicine. Transfus Med Rev 2002 16 : 131 43. (Pubitemid 34292973)
16. Jacoby GA, Hunt JV, Kosinski KS, Demirjian ZN, Huggins C, Etkind P, Marcus LC, Spielman A. Treatment of transfusion-transmitted babesiosis by exchange transfusion. N Engl J Med 1980 303 : 1098 100.
17. Pantanowitz L, Cannon ME. Extracellular Babesia microti parasites. Transfusion 2001 41 : 400. (Pubitemid 32378093)
18. Setty S, Khalil Z, Schori P, Azar A, Ferrieri P. Two atypical cases from Minnesota and review. Am J Clin Pathol 2003 120 : 554 9.
19. Carter WJ, Yan Z, Cassai ND, Sidhu GS. Detection of extracellular forms of Babesia in the blood by electron microscopy: a diagnostic method for differentiation from Plasmodium falciparum. Ultrastruct Pathol 2003 27 : 211 6. (Pubitemid 37072163)
20. Klein HG, Anderson D, Bernardi MJ, Cable R, Carey W, Hoch JS, Robitaille N, Silviotti ML, Smaill F. Pathogen inactivation: making decisions about new technologies. Report of a consensus conference. Transfusion 2007 47 : 2338 46. (Pubitemid 47228493)
21. US Food and Drug Administration. FDA workshop to consider approaches to reduce the risk of transfusion-transmitted babesiosis in the United States. [September 12, 2008, Lister Hill Center Auditorium, Building 38A, National Institute of Health, 8800 Rockville Pike, Bethesda, MD 20894] [cited 2009 Jun 23]. Available from: URL: http://wwww.fda.gov/downloads/BiologicsBloodVaccines/ NewsEvents/WorkshopsMeetingsConferences/TranscriptsMinutes/UCM051501.pdf
22. Gleason NN, Healy GR, Western KA, Benson GD, Schultz MG. The "Gray" strain of Babesia microti from human case established in laboratory animals. J Parasitol 1970 56 : 1256 7.
23. Grellier P, Benach J, Charneau S, Gil H, Monslave G, Alfonso R, Lynette S, Lin L, Steiert M, Dupuis K. Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components. Transfusion 2008 48 : 1676 84.
24. Akompong T, Ghori N, Haldar K. In vitro activity of riboflavin against the human malaria parasite Plasmodium falciparum. Antimicrob Agents Chemother 2000 44 : 88 96. (Pubitemid 30010677)
25. Herwaldt BL, Kjemtrup AM, Conrad PA, Barnes RC, Wilson M, McCarthy MG, Sayers MH, Eberhard ML. Transfusion-transmitted babesiosis in Washington State: first reported case caused by a WA1-type parasite. J Infect Dis 1997 175 : 1259 62. (Pubitemid 27176525)
26. Kjemtrup AM, Lee B, Fritz CL, Evans C, Chervenak M, Conrad PA. Investigation of transfusion transmission of a WA1-type babesial parasite to a premature infant in California. Transfusion 2002 42 : 1482 7.